BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28437737)

  • 21. The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25- FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia.
    Toldi G; Saito S; Shima T; Halmos A; Veresh Z; Vásárhelyi B; Rigó J; Molvarec A
    Am J Reprod Immunol; 2012 Aug; 68(2):175-80. PubMed ID: 22510013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating CD4+CD25+ regulatory T cells in patients with pancreatic cancer.
    Yamamoto T; Yanagimoto H; Satoi S; Toyokawa H; Hirooka S; Yamaki S; Yui R; Yamao J; Kim S; Kwon AH
    Pancreas; 2012 Apr; 41(3):409-15. PubMed ID: 22158072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of correlation between Treg quantification assays in inflammatory bowel disease patients.
    Brandhorst G; Petrova DT; Weigand S; Eberle C; von Ahsen N; Schmitz J; Schultze FC; Raddatz D; Karaus M; Oellerich M; Walson PD
    World J Gastroenterol; 2015 Mar; 21(11):3325-9. PubMed ID: 25805940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4(+) and CD8(+) regulatory T cells in chronic rhinosinusitis mucosa.
    Pant H; Hughes A; Schembri M; Miljkovic D; Krumbiegel D
    Am J Rhinol Allergy; 2014; 28(2):e83-9. PubMed ID: 24717938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
    Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
    Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
    Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
    Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
    Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
    Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower numbers of FoxP3 and CCR4 co-expressing cells in an elevated subpopulation of CD4+CD25high regulatory T cells from Wegener's granulomatosis.
    Klapa S; Mueller A; Csernok E; Fagin U; Klenerman P; Holl-Ulrich K; Gross WL; Lamprecht P
    Clin Exp Rheumatol; 2010; 28(1 Suppl 57):72-80. PubMed ID: 20412707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of regulatory CD4+CD25+ Foxp3 T cells in bronchial asthma in Egyptian children.
    Bakr SI; Mahran MZ; Soliman DA
    Egypt J Immunol; 2013; 20(2):29-38. PubMed ID: 24617045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4
    Kindlund B; Sjöling Å; Yakkala C; Adamsson J; Janzon A; Hansson LE; Hermansson M; Janson P; Winqvist O; Lundin SB
    Gastric Cancer; 2017 Jan; 20(1):116-125. PubMed ID: 26782287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibition of CD4+ CD25+ regulatory T cells in chronic hepatitis B patients].
    Zhang HH; Guo F; Fei R; Ma H; Cong X; Wei L; Chen HS
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):511-5. PubMed ID: 18649763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
    Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
    Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis.
    Ferri S; Longhi MS; De Molo C; Lalanne C; Muratori P; Granito A; Hussain MJ; Ma Y; Lenzi M; Mieli-Vergani G; Bianchi FB; Vergani D; Muratori L
    Hepatology; 2010 Sep; 52(3):999-1007. PubMed ID: 20683931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells.
    Duggleby RC; Shaw TN; Jarvis LB; Kaur G; Gaston JS
    Immunology; 2007 May; 121(1):129-39. PubMed ID: 17425604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma.
    Wei S; Kryczek I; Edwards RP; Zou L; Szeliga W; Banerjee M; Cost M; Cheng P; Chang A; Redman B; Herberman RB; Zou W
    Cancer Res; 2007 Aug; 67(15):7487-94. PubMed ID: 17671219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.